HOMEOVOX

Medicinal product

(Invented) name

HOMEOVOX

Active substance (s)

Aconitum napellus 3 CH/Arum triphyllum 3 CH/Ferrum phosphoricum 6 CH/Calendula officinalis 6 CH/Spongia tosta 6 CH/Atropa belladonna 6 CH/Mercurius solubilis 6 CH/Hepar sulphuris calcareum 6 CH/Kalium bichromicum 6 CH/Populus candicans 6 CH/Bryonia dioica 3 CH

Strength

0,09 mg/0,09 mg/0,09 mg/0,09 mg/0,09 mg/0,09 mg/0,09 mg/0,09 mg/0,09 mg/0,09 mg/0,09 mg

Pharmaceutical form

dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

Marketing authorisation holder

UAB Tojaris projektai, Lietuva

Date of authorisation

2013-01-28

Date of renewal

Documents

0138-01 Homeovox tabletes PZ PL.doc

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Aconitum napellus 3 CH	0,09 mg
Arum triphyllum 3 CH	0,09 mg
Ferrum phosphoricum 6 CH	0,09 mg
Calendula officinalis 6 CH	0,09 mg
Spongia tosta 6 CH	0,09 mg
Atropa belladonna 6 CH	0,09 mg
Mercurius solubilis 6 CH	0,09 mg
Hepar sulphuris calcareum 6 CH	0,09 mg
Kalium bichromicum 6 CH	0,09 mg
Populus candicans 6 CH	0,09 mg
Bryonia dioica 3 CH	0,09 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
54905	68930	1068930	lizdinė plokštelė	N60		Nereceptinis	LT/L/13/0138/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
	Išregistruotas
2013-01-28	Registruotas